ITM 74D
Alternative Names: ITM-74DLatest Information Update: 13 Oct 2024
Price :
$50 *
At a glance
- Originator ITM Solucin
- Class Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Cancer; Fibrosis; Inflammation
Most Recent Events
- 13 Oct 2024 ITM 74D is available for licensing as of 03 Sep 2024. www.itm-radiopharma.com/itm-partnering-opportunities
- 08 Sep 2024 Preclinical trials in Cancer (Diagnosis) in Germany (Parenteral) (ITM Solucin pipelines; September 2024)
- 08 Sep 2024 Preclinical trials in Fibrosis (Diagnosis) in Germany (Parenteral) (ITM Solucin pipelines; September 2024)